Fast Five Quiz: Acute Myeloid Leukemia Guidelines

Elwyn C. Cabebe, MD

Disclosures

December 14, 2023

Acute myeloid leukemia (AML) is a heterogeneous, hematologic bone marrow disease characterized by the clonal expansion of precursors — myeloid blasts — in the bone marrow, peripheral blood, and/or other tissues. Most subtypes of AML can be distinguished from related blood disorders by the presence of more than 20% blasts in the patient's bone marrow. AML is the most common form of acute leukemia among adults and causes the most deaths from leukemia in the United States each year. Multiple factors have been implicated in the causation of AML, including antecedent drug exposures, environmental exposures, familial syndromes, and hematologic disorders. However, no identifiable risk factor is found in most patients who present with de novo AML.

Are you ready to identify, diagnose, manage, and treat AML on the basis of the most recent clinical guidelines? Test yourself with a short quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....